Sponsored

From Point A to Point Unbelievable: How Buoy Health scaled from idea to unbelievable A.I. success story.

This article is presented by TC Brand Studio. This is paid content, TechCrunch editorial was not involved in the development of this article. Reach out to learn more about partnering with TC Brand Studio.

Sponsored by:

Scaling a startup is undoubtedly the most amazing ride any entrepreneur can take—a journey filled with humor, challenges, and hard-fought wins. Watch this session for an interactive conversation on what it takes to scale a startup. Andrew Le, CEO, Buoy Health will reflect on how he took his company from an inspiring idea (aka Point A) to a massive AI success with more than 30 million users seeking healthcare advice through the Buoy platform (aka Point Unbelievable). This promises to be a fun, lively discussion you won’t want to miss!

Speakers

Jamal Khan | Chief Growth & Innovation Officer, Connection

As Chief Growth and Innovation Officer, Jamal Khan leads multiple teams across several areas, including: internal efficiencies and automation; new products and services; brand equity, demand generation, and digital engagement; and data and eCommerce. Khan also oversees all aspects of Connection’s international operations. Khan is an industry expert with years of engineering expertise in the areas of Trading Systems, eCommerce, and Cyber Security. He is a Guest Lecturer at Columbia University’s Graduate School of Business, on the subject of Artificial Intelligence. He is also an inventor of six approved patents related to human-machine interface design, data orchestration, and machine learning, and has been actively involved in technology startups as both an investor and mentor. Mr. Khan joined Connection through the company’s 2016 acquisition of GlobalServe Inc., where he served as Chief Executive Officer. Prior to GlobalServe, Mr. Khan worked in leadership capacities at Instinet, VeriSign, Arpatech, and Merck Medco.

Andrew Le | CEO & Co-Founder, Buoy Health

Since founding Buoy out of Harvard Innovation Labs in 2014, Andrew has led the company through two successful funding rounds, raising over $67 million, with prominent healthcare investors including Optum, Cigna, Humana, WR Hambrecht + Co., and F-Prime. In 2020, Andrew was named by Business Insider as one of 30 healthcare leaders under 40 to watch, a Digital Innovator by Employee Benefits News, one of Boston Business Journal’s Top 40 Under 40 leaders, and recognized as a TEDMED Hive Innovator. Andrew holds a doctorate of medicine from Harvard Medical School and graduated magna cum laude from Harvard College.